Applicants may request up to $60,000 (direct + indirect costs) Total Costs for one year or well justified requests for support of up to $100,000. A
narrative justification should be provided only for any major equipment (cost greater than $5,000) deemed to be necessary for the proposed project.
The number of awards will depend upon the number, quality, duration, and cost of the applications received.
Awards will be made as subcontracts from the DiaComp Coordinating and Bioinformatics Unit (CBU) at the Georgia Regents University and not directly by the
NIH. Funded awards are not allowed to submit a competitive renewal application and unfunded applications are not allowed to revise and resubmit an amended
application. Multi-year funding requests are not allowed.
Back to Top
Each application will receive a primary review by multiple external referees and be given scores for Significance, Investigator,
Innovation, Approach, Environment and an Overall Score based on the
NIH Scoring System for Research Applications. Scores will range from 1 to 9, where a score of 1-3 indicates an application addressing
a problem of high importance/interest in the field and may have some or no weaknesses. A score of 4-6 may be addressing a problem of high
importance in the field, but weaknesses in the criteria bring down the overall impact to medium. A score of 7-9 may be addressing a problem
of moderate/high importance in the field, but weaknesses in the criteria bring down the overall impact to low. A score of 9 indicates an
application with serious and substantive weaknesses with very few strengths. A score of 5 is considered an average score. The entire scale
(1-9) should always be considered. Please note that the Overall Score is NOT an average of the other scores.
Reviewers will strongly consider the goal of the program to support discovery (hypothesis generating) and innovative (high risk/high reward)
research. The DiaComp External Evaluation Committee (EEC) will provide a secondary review of all applications. Applications that are
incomplete, non-compliant and/or nonresponsive will not be reviewed. No additional materials may be submitted after the receipt date.
Scientists from the applicant institution are in conflict and excluded from review. Written comments will be provided for all reviewed
applications. Final funding decisions will be made by the NIH. All decisions are final and appeals will not be accepted for applications
submitted in response to this solicitation. Funded awards are not allowed to submit a competitive renewal application and unfunded
applications are not allowed to revise and resubmit an amended application. Multi-year funding requests are not allowed.
Back to Top
|January 1, 2016
RFA for DiaComp Pilot Projects is posted on DiaComp website, MMPC and other related websites, and notification of the postings is sent to
all US academic and research institutions.
|June 10, 2016
||Grants Submitted to CBU (Dr. Richard McIndoe, CA 4127, Georgia Regents University, Augusta, Georgia, 30912) |
||Projected start date for DiaComp Pilot Project Funding
Back to Top
The application is the standard PHS 398 form including face, abstract,
detailed budget, biographical and other support pages (up to 4 pages), and research plan. The research plan (Sections A-D are limited to 5 pages)
should include the following sections:
- Specific Aims,
- Background and Significance,
- Preliminary Studies,
- Research Design and Methods,
- Literature Cited,
- Vertebrate Animals
- Sharing Plan
All applications must be submitted via the DiaComp website (PDF format only please).
Eligible Project Directors/Principal Investigators:
Individuals with the skills, knowledge, and resources necessary to carry out the proposed research
are invited to work with their institution to develop an application for support. Individuals from
underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged
to apply for NIH support. New investigators are encouraged to apply, but they must have a full-time faculty
position or an equivalent position at non-academic institutions.
Public/State Controlled Institution of Higher Education; Private Institution of Higher Education;
Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled
Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Nonprofit with
501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS
Status (Other than Institution of Higher Education); Non-domestic (non-U.S.) Entity; Small Business;
For-Profit Organization (Other than Small Business); State Government; Regional Organization; U.S.
Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native
American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated
Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.
Back to Top
Please note that projects devoted to the development of new techniques and tests for the metabolic characterization of
mice are NOT responsive to this announcement and are better suited for the MMPC Pilot and Feasibility Grant Program
(please see www.mmpc.org for more details). In brief, this program supports applications to:|
- Develop new technologies or miniaturization of existing technologies for use in mice,
- Develop applications of existing technologies for use in mice,
- Provide new tests to meet identifiable, outstanding needs necessary to phenotype mouse models of metabolic disease, and
- Establish new types of mathematical models, informatics, databases or products that augment the mission of the center.
When appropriate, the use of human samples is strongly encouraged, including the linking of human samples to existing tissue repositories and databases (e.g. the
NIDDK repository [www.niddkrepository.org/home/] or dkNET [http://www.dknet.org/]). Research involving human subjects is limited to observational studies with non-invasive or minimally invasive
testing and must have IRB approval that includes the collection and use of human samples for research purposes. Interventional clinical trials are beyond the scope
of this program.|
A summary of progress of funded projects is due two months following the completion
of the funding period.
DiaComp awardees must follow NIH and HHS policies regarding the sharing of data and resources with the scientific community
(http://grants.nih.gov/grants/sharing.htm) and agree to submit to the
DiaComp web portal all data and resources resulting from the execution of the awarded application. Data and resources may
include, but are not limited to:
- histology images,
- experimental data,
- RNAseq, and
- progress report(s).
All data and resources generated with DiaComp support will be made immediately available to "active" DiaComp awardees (see below) and publicly available
on the DiaComp website: (1) at the time of first publication, or (1) one year after the award ends. Under certain circumstances,
investigators may request an exception to the DiaComp two year public release policy by contacting NIH Program staff and requesting
a waiver. Such requests will be reviewed on a case-by-case basis and waivers will be granted only with sufficient and compelling prior justification.
DiaComp awardees are considered "active" and granted full access to the DiaComp website as members of the DiaComp "Steering Committee" for the duration of
their funding period plus 4 years. Outgoing awardees may request an extension from NIH Program staff beyond this "active" period.
Proprietary data and resources will be excluded from sharing consistent with NIH and HHS policies
Financial acknowledgment of award: Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole
using funds from the Diabetic Complications Consortium (DiaComp) using the following
text: 'Financial support for this work provided by the NIDDK Diabetic Complications Consortium (DiaComp,
www.diacomp.org), grant DK076169'.
For presentations and slides, please use the PowerPoint slide with the funding source logo found in the zip file here -
http://www.diacomp.org/images/diacomp-logos.zip - to
indicate that DiaComp is a funding source for your presentation.
Back to Top
Richard McIndoe, Ph.D. (Coordinator)
Coordinating and Bioinformatics Unit
Georgia Regents University
Center for Biotechnology and Genomic Medicine
1120 15th Street, CA4124
Augusta, GA 30912-4810
Back to Top